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Inflammatory responses have been implicated in several forms of infant deaths (sudden
expected deaths and stillbirths) and the initiation of pre-term births. In this study,
we examined matched samples of term maternal blood, cord blood, and amniotic
fluid obtained from 24 elective cesarean deliveries for both pro- and anti-inflammatory
cytokines thought to be important in maintaining a balanced response leading to
successful pregnancy outcome. These included interleukin (IL)-1β, IL-6, IL-8, tumor
necrosis factor-α (TNF-α), interferon-γ (IFN-γ), IL-10, and IL-1 receptor antagonist (IL-
1ra). Amniotic fluid levels for each of the cytokines examined were significantly higher than
those for cord blood or maternal plasma. While pro-inflammatory cytokines were higher in
amniotic fluid associated with male fetuses compared with females, the major significant
difference was higher levels of IL-1ra in amniotic fluid associated with female fetuses.
Our study supports similar findings for cytokines during mid-trimester, which noted that
amniotic fluid levels were higher than those in maternal blood. Our study suggests
that maternal decidua secretes additional IL-ra in the presence of a female conceptus
which improves the likelihood of a good outcome compared to pregnancies with
male fetuses.
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Introduction
A balanced cytokine response is thought to be important in maintaining pregnancy (1). Our
previous studies indicated that there were differences in inflammatory responses associated with
sex and that testosterone levels present during critical development periods might influence pro-
inflammatory responses to infection (2, 3). There is an excess of males among infants who die
suddenly and unexpectedly (4, 5), stillbirths (6, 7), and pre-term births (8, 9). As inflamma-
tion has been implicated in each of these conditions, we examined cytokine levels in matched
sets of samples of maternal plasma, cord blood, and amniotic fluid collected during elective
term cesarean deliveries to determine: if in the third trimester, cytokine levels in maternal
blood and amniotic fluid were higher than those reported for the second trimester (10); if
there was a correlation between cytokine levels in maternal or cord blood or amniotic fluid
samples; if there were differences in cytokine levels from samples associated with male and
female fetuses.
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Materials and Methods
Matched samples of maternal plasma, cord blood, and amniotic
fluid were obtained from elective term cesarean section deliv-
eries as part of a study approved by the Hunter New England
Ethics Committee, Mapping the Progress of Human Parturition
(02/06/12/3.13). Twenty-four sets of samples were examined,
12 from pregnancies with a female infant and 12 from preg-
nancies with a male infant. A Bio-Plex suspension array assay
(Bio-Rad) was used to quantitate interleukin (IL)-1β, IL-6, IL-8,
interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and the
anti-inflammatory mediators IL-10 and IL-1 receptor antagonist
(IL-1ra) (11).
The samples were stored at  80°C. Specimens were thawed,
vortexed, and a 200µl aliquot filtered with a 0.2µm centrifugal
filter (Millipore). The filtrate was either refrozen at 80°C for later
analysis or immediately diluted for cytokine assay in cold BioPlex
diluent. Samples from maternal or cord blood were diluted one
volume in two volumes and amniotic fluidwas diluted one volume
in three volumes of Bio-Plex sample diluent.
Results were expressed in pgml 1. Data were tabulated as
median and ranges. Spearman’s non-parametric correlations were
used to determine relationships between variables. Student’s t-test
was used on log-transformed data to assess differences in cytokine
levels between the three sources of samples and betweenmale and
female infants. Significance was set at 5%.
Results
The first objective of the study was to compare cytokine levels
in maternal blood and amniotic fluid with data reported for an
Australian population at mid-trimester (Table 1). In the current
study, the median gestational age (GA) at time of sampling was
39.1 weeks. In many cord blood and maternal plasma samples in
the current study, levels of IFN-γ, TNF-α, and IL-1β were below
the lower limits of detection.
Median levels ofmaternal IL-1β, IFN-γ, TNF-α, and IL-ra were
higher during the second trimester. IL-6, IL-8, and IL-10 were
higher in the third trimester. For amniotic fluid, median levels for
each of the cytokines assessed in this studywere higher in the third
trimester.
At mid-trimester, IFN-γ and TNF-α were found at higher val-
ues in maternal sera compared with amniotic fluid. In this study
of samples collected in the third trimester, all the cytokines tested
were found at significantly higher levels (p< 0.00001) in amniotic
fluid compared with maternal plasma (Table 2).
In the mid-trimester samples, IL1-ra levels increased signifi-
cantly with the age of the mother (10). In this study of samples
obtained at term, the only correlation with maternal age was IL-8
(r= 0.5789, n= 24, p= 0.0025, α= 1).
The second objective was to determine if therewas a correlation
between cytokine levels in maternal or cord blood or amniotic
fluid samples obtained during the third trimester. Analyses among
the three categories of samples were carried out on the pro-
inflammatory IL-6 and IL-8 and the anti-inflammatory IL-10 and
IL-1ra.
Levels of each of the cytokines tested were significantly higher
in amniotic fluid compared with the matched maternal plasma
TABLE 1 | Comparison of cytokine levels in maternal blood (a) and amniotic




Median (range) Median (range)
(pgml 1) N=33 (pgml 1) N=24
IFN-γ 113 (34–431) 41 (<11–772)
IL-1β 7 (2–360) <2:4 (<2:4–21)
IL-6 22 (6–2116) 59 (10–74)
IL-8 17 (3–98) 90 (36–3289)
TNF-α 53 (4–392) 16 (<5:4–32)
IL-10 3 (<1–1206) 11 (<1:8–160)




Median (range) Median (range)
(pgml 1) (n=100) (pgml 1) (n=24)
IFN-γ 22 (5–132) 1804 (15–14; 417)
IL-1β 1:5 (<1–5) 45 (<2:4–69)
IL-6 230 (28–2621) 2118 (646–12; 928)
IL-8 188 (29–1648) 2066 (578–7082)
TNF-α 18 (<1–153) 538 (24–3176)
IL-10 3 (<1–9) 73 (<1:8–303)
IL-1ra 758 (85–3833) 2357 (330–6295)
TABLE 2 | Comparison of median cytokine levels (pgml 1) in matched
samples of maternal plasma, cord blood and amniotic fluid collected from
elective cesarean deliveries (n= 24).
Cytokine Median (range) (pgml 1)
Maternal plasma Cord blood Amniotic fluid
Il-6 59 (10–74) 54 (12–3860) 2118 (646–12; 928)**
Il-8 90 (36–3289) 95 (23–333) 2066 (578–7082)**
IL-10 11 (<1:8–160) 12 (4–58) 73 (<1:8–303)**
IL1-ra 90 (<4–230) 85 (30–325) 2357 (330–6295)**
**Significant differences between amniotic fluid and cord blood and amniotic fluid and
maternal plasma (p< 0.00001).
or cord blood (Table 2). There were no differences in levels of
cytokines between maternal plasma and cord blood.
There was a significant correlation between levels of IL-10 in
maternal plasma and cord blood (r= 0.8506, n= 24, p= 0.001,
α= 2). There were no correlations between levels of any of
the cytokines detected in cord blood and amniotic fluid. There
was a significant correlation between levels of IL-1ra in mater-
nal plasma and amniotic fluid (r= 0.7293, n= 24, p= 0.001,
α= 2).
The third objective was to determine if there were differences
in cytokine levels in samples associated with male and female
fetuses (Table 3). The levels of the anti-inflammatory IL-1ra
were significantly higher in amniotic fluid from female infants
(p= 0.0009). In amniotic fluid, median IL-1β levels were higher
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TABLE 3 | Comparison by sex of the infant (males=12, females= 12) of
median cytokine levels in maternal plasma, cord blood, and amniotic fluid
obtained during elective cesarean delivery.
Cytokines Median (range) (pgml 1)
Males Females
Maternal plasma
Il-6 64 (10–174) 46 (29–170)
Il-8 103 (88–3289) 78 (36–563)
IL-10 10 (<1–15) 13 (4–160)
IL1-ra 76 (4–220) 118 (83–230)
Cord blood
Il-6* 70 (32–386) 39 (12–157)
Il-8 99 (59–197) 64 (23–333)
IL-10 10 (4–22) 15 (4–58)
IL1-ra 125 (30–325) 73 (30–293)
Amniotic fluid
Il-6 1218 (398–12; 928) 2271 (292–10; 739)
Il-8 2403 (621–9179) 1794 (578–4186)
IL-10 112 (<1:8–303) 56 (9–226)
IL1-ra** 1839 (330–5065) 3909 (1786–8837)
*p0.05.
**p=0.0009.
in samples from males (42 pgml 1) compared with those from
females (28 pgml 1); however, there were two samples from
females and three samples from males in which levels of IL-
1β were below the lower limits of detection. There were nega-
tive correlations between IL-1β and IL-1ra: for all 24 samples,
r= 0.296 but thesewere not significant. The negative correlation
was more pronounced for samples from females (r= 0.3457)
than those from males (r= 0.1396). For maternal plasma, there
were no significant differences between the levels of cytokines
and the sex of the infant. The only significant difference for cord
blood was higher median levels of IL-6 for males (70 pgml 1)
compared with those for females (39 pgml 1) (p< 0.05). IL-1β
was measured; however, it was detectable in only four samples of
maternal plasma and only one cord blood sample; therefore, it was
not analyzed further.
Maternal plasma levels of IL-6, IL-8, IL-10, and IL-1ra were
assessed in relation to bodymass index (BMI) of themother, birth
weight of the infant and GA at birth. For all samples, neither IL-
8 nor IL-6 was correlated with any of these three factors. IL-10
was not correlated with BMI or birth weight, but it increased with
GA (r= 0.3537, n= 24, p< 0.05, α= 1). IL-1ra was not corre-
lated with birth weight or BMI, but it decreased as GA increased
(r= 0.5885, n= 24, p= 0.005, α= 2). For GA, there was a
significant association between IL-8 levels with female infants
(r= 0.8860, n= 12, p< 0.001, α= 2), and for males, there was
a significant negative correlation with IL-1ra levels (r= 0.9115,
n= 12, p< 0.001, α= 2).
For cord blood samples, there was no correlation between
maternal BMI and any cytokine assessed. For birth weight, there
were positive correlations with cord blood IL-6 levels for both
females (r= 0.666, n= 12, p< 0.05, α= 2) andmales (r= 0.5244,
n= 12, p< 0.05, α= 1). For GA, there were no correlations with
cytokine levels in cord blood for female fetuses. For males, there
was a positive correlation between IL-6 levels and GA (r= 0.6819,
n= 12, p< 0.02, α= 2.
Although IL-1ra levels were significantly higher in amniotic
fluid of female fetuses, when assessed by the sex of the fetus,
the only significant correlation was between GA of male fetuses
and IL-1ra (r= 0.7225, n= 12, p= 0.01, α= 1). There was no
correlation between birth weight or maternal BMI and levels of
cytokines in amniotic fluid of either males or females.
In this study, IL-6 and IL-8 in amniotic fluid rose with GA
of the infant; however, only the correlation with IL-6 levels was
significant (r= 0.3765, n= 24, p= 0.05, α= 1). Levels of the anti-
inflammatory IL-10 and IL-1ra declined with GA, but these were
not significant.
Discussion
The objectives of the study were to determine: if in the third
trimester, cytokine levels in amniotic fluid and maternal plasma
were higher than those reported for second trimester; if there
was a correlation between cytokine levels in the samples obtained
frommother and infant; if therewere differences in cytokine levels
associated with male and female fetuses.
To examine objective 1, data from Chow et al. (10) were com-
pared with our findings as both studies used the same method for
detection of cytokines in maternal blood and amniotic fluid. In
both studies, IL-6, IL-8, and IL-1ra were detected in all samples of
maternal blood. In the mid-trimester blood samples, IFN-γ, IL-
1β, and TNF-α were within the range of detection. In the third
trimester blood samples, themedian levels of these cytokines were
lower and many had undetectable levels. In both studies, IFN-γ,
IL-6, IL-8, and IL-1ra were detected in all amniotic fluid samples.
Themedian levels of all the cytokines tested (Table 1) were higher
in amniotic fluid during the third trimester.
Median cytokine levels in 110 third trimester amniotic fluid
samples from cesarean section deliveries not in labor (median age
39weeks) were lower for IL-6 (764 pgml 1), IL-8 (629 pgml 1),
IL-10 (6.6 pgml 1), and TNF-α (10.5 pgml 1) (12) than those
reported in the present study. The only significant differences
between these cytokine levels and those in samples taken during
amniocentesis (median GA 17weeks) were for IL-10, which was
increased and TNF-α which was decreased (12). The higher levels
reported in Table 1 are unlikely to be associated with different
GAs; the median GA for both studies was 39weeks. Some of the
differences might be attributed to methods for detection of the
cytokines; the study by Weissenbacher et al. (12) used an enzyme
linked immunosorbent assay.
There were few correlations of cytokine levels between sam-
ples from mother and infant. For the samples obtained at mid-
trimester, macrophage inflammatory protein (MIP)-1β levels in
maternal blood correlatedwith those in amniotic fluid (10). In this
study, levels of IL-1ra in maternal plasma correlated with those in
amniotic fluid and maternal IL-10 levels correlated with those in
cord blood.
There were no sex-specific differences in cytokine levels in
maternal plasma (Table 3). For cord blood, IL-6 was higher
in males. For amniotic fluid, most of the pro-inflammatory
cytokines, except IL-6, were higher in samples from male fetuses.
The major significant difference for amniotic fluid samples was
higher levels of IL-1ra in amniotic fluid of female fetuses.
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The study of Chow et al. (10) found higher levels of IL-1ra
in amniotic fluid compared with those reported by Bry et al.
(13); at mid-trimester, there were no sex-specific differences. Our
findings agree with those of Bry et al. for third trimester fetuses;
the levels for IL-1ra were higher for female fetuses. The correlation
that we observed between maternal plasma and amniotic fluid
levels of IL-1ra suggests that the pregnant decidua secretes IL-1ra
into both amniotic fluid and maternal blood. The relatively high
levels of IL-1ra in amniotic fluid compared with maternal blood
suggest that IL-1ra is preferentially secreted into the amniotic
fluid or that clearance from this compartment is slower than from
maternal plasma or a combination of both effects.
It has been proposed that pro-inflammatory cytokines (e.g.,
IL-6) are important in triggering birth (14, 15). For maternal
plasma, both anti-inflammatory cytokines (IL-1ra and IL-10)
declined with GA. In pregnancies, where the fetus was male
the decrease in IL-1ra with GA was significant, and in male
fetuses, there was an increase with GA in the pro-inflammatory
cytokine IL-6 in their cord blood. In addition, if the fetus was
male, there was a negative correlation between IL-1ra and GA
in amniotic fluid. These findings indicate an increasing pro-
inflammatory environment as term approaches; and it is most
evident in pregnancies in which the fetus is male. IL-1ra levels
were higher in the amniotic fluid of female fetuses, suggesting that
if the fetus is female not only do levels of the anti-inflammatory
cytokine IL-1ra remain constant but also they are significantly
higher than those found in amniotic fluid when the fetus
is male.
These findings provide preliminary normative data for our
population for cytokine levels in late pregnancy and indicate
that there are differences in inflammatory responses associated
with male and female fetuses. They also indicate that sex of
the fetus needs to be assessed in relation to the role of inflam-
matory responses in the outcome of pregnancy. More work is
required to determine the interactions between factors reported to
affect inflammatory responses such as higher testosterone levels
associated with male fetuses (3, 16) and BMI, which is associ-
ated with increased in pro-inflammatory responses (17, 18). It is
interesting to note that, in this study, we found that the baby’s
birth weight was positively correlated with cord blood levels of
the pro-inflammatory cytokine, IL-6. Smoking is associated with
decreased anti-inflammatory responses (19). The small number of
smokers in the study did not allow us to examine the effect of this
important risk factor.
Our results do indicate that female fetuses might be better
able to deal with infection and inflammation in utero than males
and mighty partly explain their lower incidences of pre-term
births, stillbirths, and unexpected deaths in infancy. Our data also
indicate that term is associated with an increase in inflammatory
cytokines and a fall in anti-inflammatory cytokines that is consis-
tent with inflammation playing a role in the onset of human labor.
While preliminary, the results are relevant to the highly topical
area of sex-specific changes in decidual immune function and the
potential effects on both male and female fetuses.
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